Sectors
The diagnostic technology developer will use the funds secured in the Robert Bosch-led round to bring its laser-based lead product to market.
Medical Surgery Technologies has developed a medical device that enables minimally invasive surgery with little user interaction.
The MedImmune-backed rare disease drug developer initially raised $60m when it went public on Nasdaq last week.
The senior home care marketplace has revealed a Tencent and Graham Holdings-backed $20m series A round alongside $3m of seed funding.
The cash is being provided in the form of equity and an access fee as the two companies form a partnership agreement to improve drug delivery systems.
Allscripts purchased a 10% stake in the cloud-based healthcare IT company, following on from a strategic partnership formed by the two in March this year.
NantCell, an immuno-oncology subsidiary of conglomerate NantWorks, has acquired biotechnology company VivaBioCell, providing Generali with an exit.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
